These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1683227)
21. Nitroglycerin-induced S-nitrosylation and desensitization of soluble guanylyl cyclase contribute to nitrate tolerance. Sayed N; Kim DD; Fioramonti X; Iwahashi T; Durán WN; Beuve A Circ Res; 2008 Sep; 103(6):606-14. PubMed ID: 18669924 [TBL] [Abstract][Full Text] [Related]
22. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin. Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388 [TBL] [Abstract][Full Text] [Related]
23. Interactions between organic nitrates and thiol groups. Abrams J Am J Med; 1991 Sep; 91(3C):106S-112S. PubMed ID: 1928200 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. Ignarro LJ; Lippton H; Edwards JC; Baricos WH; Hyman AL; Kadowitz PJ; Gruetter CA J Pharmacol Exp Ther; 1981 Sep; 218(3):739-49. PubMed ID: 6115052 [No Abstract] [Full Text] [Related]
25. Structure-activity relationship of organic nitrates for activation of guanylate cyclase. Schröder H; Noack E Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):235-46. PubMed ID: 2895614 [TBL] [Abstract][Full Text] [Related]
26. Characterization of the mechanism of cytochrome P450 reductase-cytochrome P450-mediated nitric oxide and nitrosothiol generation from organic nitrates. Li H; Liu X; Cui H; Chen YR; Cardounel AJ; Zweier JL J Biol Chem; 2006 May; 281(18):12546-54. PubMed ID: 16527817 [TBL] [Abstract][Full Text] [Related]
27. Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo. Mülsch A; Bara A; Mordvintcev P; Vanin A; Busse R Br J Pharmacol; 1995 Nov; 116(6):2743-9. PubMed ID: 8590999 [TBL] [Abstract][Full Text] [Related]
28. The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: role in nitrate tolerance. Mollace V; Muscoli C; Dagostino C; Giancotti LA; Gliozzi M; Sacco I; Visalli V; Gratteri S; Palma E; Malara N; Musolino V; Carresi C; Muscoli S; Vitale C; Salvemini D; Romeo F Pharmacol Res; 2014 Nov; 89():29-35. PubMed ID: 25174989 [TBL] [Abstract][Full Text] [Related]
29. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. Katsuki S; Arnold W; Mittal C; Murad F J Cyclic Nucleotide Res; 1977 Feb; 3(1):23-35. PubMed ID: 14978 [TBL] [Abstract][Full Text] [Related]
30. Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery. MacAllister RJ; Calver AL; Riezebos J; Collier J; Vallance P J Pharmacol Exp Ther; 1995 Apr; 273(1):154-60. PubMed ID: 7714761 [TBL] [Abstract][Full Text] [Related]
32. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro. Bath PM Eur J Clin Pharmacol; 1993; 45(1):53-8. PubMed ID: 8405030 [TBL] [Abstract][Full Text] [Related]
33. Exogenous modification of nitrovasodilator-induced cyclic GMP formation in human lymphocytes. Vuorinen P Pharmacol Toxicol; 1992 Jun; 70(6 Pt 1):463-7. PubMed ID: 1359526 [TBL] [Abstract][Full Text] [Related]
34. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade. Henry PJ; Horowitz JD; Louis WJ J Pharmacol Exp Ther; 1989 Feb; 248(2):762-8. PubMed ID: 2563771 [TBL] [Abstract][Full Text] [Related]
35. Effects of in vivo SIN1 treatment on nitrovasodilator relaxation and on EDRF-mediated responses in rat aorta. Berkenboom G; Fang ZY; Unger P; Fontaine J J Cardiovasc Pharmacol; 1990 Oct; 16(4):636-40. PubMed ID: 1706806 [TBL] [Abstract][Full Text] [Related]
36. Vascular and hemodynamic differences between organic nitrates and nitrites. Bauer JA; Nolan T; Fung HL J Pharmacol Exp Ther; 1997 Jan; 280(1):326-31. PubMed ID: 8996213 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of platelet activating factor-induced platelet aggregation by molsidomine, SIN-1, and nitrates in vitro and ex vivo. Gerzer R; Drummer C; Karrenbrock B; Heim JM J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S115-9. PubMed ID: 2484688 [TBL] [Abstract][Full Text] [Related]
38. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase]. Karrenbrock B; Grewe R; Loeschke K; Gerzer R Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):251-4. PubMed ID: 2882462 [TBL] [Abstract][Full Text] [Related]
39. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters. Greenberg SS; Cantor E; Ho E; Walega M J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847 [TBL] [Abstract][Full Text] [Related]
40. Nitrovasodilators as a new class of ocular hypotensive agents. Nathanson JA J Pharmacol Exp Ther; 1992 Mar; 260(3):956-65. PubMed ID: 1532035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]